Literature DB >> 7034053

Release of prostaglandin I2-like activity from the rat aorta: effect of captopril, furosemide, and sodium.

J M Sullivan, D R Patrick.   

Abstract

The effect of captopril, furosemide, indomethacin and intake of sodium on the production of PGI2-like material was studied in the rat aorta. Release of PGI2-like material from these vessels was estimated by its ability to inhibit ADP-induced platelet aggregation. Pretreatment with indomethacin (15 mg/kg/day) reduced the capacity of the aorta to release PGI2-like material. Pretreatment with captopril (10 mg/kg/day) had no effect. Intravenous furosemide (60 microgram/ml plasma volume) increased the capacity of the aorta to inhibit by 28% (p less than 0.25). The inhibitory capacity of aorta removed from rats on a low sodium diet did not differ from those on a high sodium diet. We conclude that the action of furosemide in reducing vascular tone may be related to stimulation of PGI2 synthesis in blood vessels whereas the effect of captopril and sodium in reducing vascular tone may involve a mechanism unrelated to PGI2 synthesis or may involve the synthesis of a prostaglandin other than PGI2.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7034053     DOI: 10.1016/0090-6980(81)90067-8

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  3 in total

1.  Converting enzyme inhibitor ramipril stimulates prostacyclin synthesis by isolated rat aorta: evidence for a kinin-dependent mechanism.

Authors:  H Scherf; R Pietsch; G Landsberg; H J Kramer; R Düsing
Journal:  Klin Wochenschr       Date:  1986-08-15

2.  Frusemide releases renin in the rat kidney when prostacyclin synthesis is suppressed.

Authors:  A E Barden; D P Mahoney; A M Tunney; R Vandongen
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

3.  Inhibition of vasoconstriction by frusemide in the rat.

Authors:  J F Gerkens; A J Smith
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.